Federal contracts

Department of Health and Human Services awarded GSK a $14M contract

Award

Amount: $14,047,403.7
Agency: Department of Health and Human Services
Sub-agency: Office of Assistant Secretary for Preparedness and Response
Recipient: Glaxosmithkline
Parent: Glaxosmithkline
Stock: GSK
Stock link: Subsidiary known by name
Signed: 24/02/20
Published: 25/09/16
Period: 24/02/21~27/05/21
Performed in: NC-4
Type: Delivery order
Industry: Research and development in biotechnology
Product category: Medical and dental equipment and supplies

The amount obligated so far; it changes as the award grows.

What it buys

Storage and stability of adjuvant AS03 lots, COVID-19 funds

Members who traded GSK within 30 days

No member traded this stock within 30 days of the award.

Other federal contracts of GSK

			Performed in	Description
09/25	Department of Health and Human Services	$18.2MModification	NC-4	Department of Health and Human Services · Medical and dental equipment and supplies contract modification
25/09/26	Department of Health and Human Services	$27.3M	NC-4	Relenza (zanamivir) Rotadisk, 5MG
24/06/17	Department of Health and Human Services	$11.5M	NC-4	Storage and stability of AS03 adjuvant for the COVID-19 federal response
24/05/10	Department of Health and Human Services	$18.2M	NC-4	H5 pandemic readiness medical countermeasures
24/02/27	Department of Health and Human Services	$15.4M	NC-4	Fill and finish of AS03 adjuvant multi-dose vials for the COVID-19 response

All federal contracts of GSK